Predictors of Temporary and Permanent Work Disability in Patients With Inflammatory Bowel Disease: Results of the Swiss Inflammatory Bowel Disease Cohort Study

被引:44
|
作者
Siebert, Uwe [1 ,2 ,3 ,4 ,5 ]
Wurm, Johannes [1 ]
Gothe, Raffaella Matteucci [1 ]
Arvandi, Marjan [1 ]
Vavricka, Stephan R. [7 ]
von Kaenel, Roland [8 ,9 ]
Begre, Stefan [8 ,9 ]
Sulz, Michael C. [6 ]
Meyenberger, Christa [6 ]
Sagmeister, Markus [6 ]
机构
[1] UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Dept Publ Hlth & Hlth Technol Assessment, A-6060 Hall In Tirol, Austria
[2] Harvard Univ, Sch Med, Inst Technol Assessment, Boston, MA USA
[3] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Dept Hlth Policy & Management, Boston, MA 02115 USA
[5] ONCOTYROL Ctr Personalized Canc Med, Div Publ Hlth Decis Modeling Hlth Technol Assessm, Innsbruck, Austria
[6] Kantonsspital, Div Gastroenterol, St Gallen, Switzerland
[7] Stadtspital Triemli, Div Gastroenterol, Zurich, Switzerland
[8] Univ Hosp Bern, Div Psychosomat Med, Dept Gen Internal Med, Inselspital, CH-3010 Bern, Switzerland
[9] Univ Bern, Bern, Switzerland
基金
瑞士国家科学基金会;
关键词
inflammatory bowel disease; Crohn's disease; ulcerative colitis; disability; multivariate analysis; QUALITY-OF-LIFE; CROHNS-DISEASE; HEALTH-CARE; EPIDEMIOLOGY; UNEMPLOYMENT; GERMANY; IMPACT; COST;
D O I
10.1097/MIB.0b013e31827f278e
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Inflammatory bowel disease can decrease the quality of life and induce work disability. We sought to (1) identify and quantify the predictors of disease-specific work disability in patients with inflammatory bowel disease and (2) assess the suitability of using cross-sectional data to predict future outcomes, using the Swiss Inflammatory Bowel Disease Cohort Study data. Methods: A total of 1187 patients were enrolled and followed up for an average of 13 months. Predictors included patient and disease characteristics and drug utilization. Potential predictors were identified through an expert panel and published literature. We estimated adjusted effect estimates with 95% confidence intervals using logistic and zero-inflated Poisson regression. Results: Overall, 699 (58.9%) experienced Crohn's disease and 488 (41.1%) had ulcerative colitis. Most important predictors for temporary work disability in patients with Crohn's disease included gender, disease duration, disease activity, C-reactive protein level, smoking, depressive symptoms, fistulas, extraintestinal manifestations, and the use of immunosuppressants/steroids. Temporary work disability in patients with ulcerative colitis was associated with age, disease duration, disease activity, and the use of steroids/antibiotics. In all patients, disease activity emerged as the only predictor of permanent work disability. Comparing data at enrollment versus follow-up yielded substantial differences regarding disability and predictors, with follow-up data showing greater predictor effects. Conclusions: We identified predictors of work disability in patients with Crohn's disease and ulcerative colitis. Our findings can help in forecasting these disease courses and guide the choice of appropriate measures to prevent adverse outcomes. Comparing cross-sectional and longitudinal data showed that the conduction of cohort studies is inevitable for the examination of disability. (Inflamm Bowel Dis 2013; 19: 847-855)
引用
收藏
页码:847 / 855
页数:9
相关论文
共 50 条
  • [21] The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort
    Hiller, Aimee
    Biedermann, Luc
    Fournier, Nicolas
    Butter, Matthias
    Vavricka, Stephan R.
    Ciurea, Adrian
    Rogler, Gerhard
    Scharl, Michael
    Anderegg, Claudia
    Bauerfeind, Peter
    Beglinger, Christoph
    Begre, Stefan
    Belli, Dominique
    Bengoa, Jose M.
    Biedermann, Luc
    Bigler, Beat
    Binek, Janek
    Blattmann, Mirjam
    Boehm, Stephan
    Borovicka, Jan
    Braegger, Christian P.
    Brunner, Nora
    Buhr, Patrick
    Burnand, Bernard
    Burri, Emanuel
    Buyse, Sophie
    Cremer, Matthias
    Criblez, Dominique H.
    de Saussure, Philippe
    Degen, Lukas
    Delarive, Joakim
    Doerig, Christopher
    Dora, Barbara
    Dorta, Gian
    Egger, Mara
    Ehmann, Tobias
    El-Wafa, Ali
    Engelmann, Matthias
    Ezri, Jessica
    Felley, Christian
    Fliegner, Markus
    Fournier, Nicolas
    Fraga, Montserrat
    Frei, Pascal
    Frei, Remus
    Fried, Michael
    Froehlich, Florian
    Funk, Christian
    Furlano, Raoul Ivano
    Gallot-Lavallee, Suzanne
    PLOS ONE, 2019, 14 (04):
  • [22] Work disability after 20 years with Inflammatory Bowel Disease - results from the IBSEN study
    Lund, C.
    Kristensen, V. A.
    Monstad, I. L.
    Solberg, I. C.
    Hovde, O.
    Huppertz-Hauss, G.
    Henriksen, M.
    Hoie, O.
    Bernklev, T.
    Jahnsen, J.
    Moum, B.
    Hoivik, M. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I555 - I555
  • [23] Work disability after 20 years with Inflammatory Bowel Disease - results from the IBSEN study
    Lund, C.
    Kristensen, V. A.
    Monstad, I. L.
    Solberg, I. C.
    Hovde, O.
    Huppertz-Hauss, G.
    Henriksen, M.
    Hoie, O.
    Bernklev, T.
    Jahnsen, J.
    Moum, B.
    Hoivik, M. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I555 - I555
  • [24] Thiopurine adverse events in patients with inflammatory bowel disease in the UK: inflammatory bowel disease BioResource cohort
    Hong, Y. Y.
    Withanachchi, D. A.
    Aslam, S. P.
    Khalid, Y.
    Shawky, R.
    Parkes, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S395 - S396
  • [25] Characterisation of Extraintestinal Manifestations in Inflammatory Bowel Disease, and Chronology of Extraintestinal relative to Intestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort
    Vavricka, Stephan R.
    Rogler, Gerhard
    Gantenbein, Claudine
    Spoerri, Muriel
    Vavricka, Mareike Prinz
    Navarini, Alexander A.
    French, Lars
    Safroneeva, Ekaterina
    Fournier, Nicolas
    Straumann, Alex
    Froehlich, Florian
    Fried, Michael
    Michetti, Pierre
    Schoepfer, Alain M.
    SWISS MEDICAL WEEKLY, 2013, 143 : 14S - 14S
  • [26] Introducing the Arabic inflammatory bowel disease disk as a tool for assessing disability in patients with inflammatory bowel disease in Jordan
    Mazzawi, Tarek
    Yadk, Ahmad
    Alghneimin, Nayef
    Hmeimat, Saad
    Al-Essa, Mohammad Saleem
    Alghafer, Haneen Abed
    Haneyah, Farah
    Alkhawaldeh, Hanan
    Samara, Eid
    Ghazal, Bandar
    ARAB JOURNAL OF GASTROENTEROLOGY, 2025, 26 (01) : 26 - 32
  • [27] The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients
    Roth, Rene
    Vavricka, Stephan
    Scharl, Michael
    Schreiner, Philipp
    Safroneeva, Ekaterina
    Greuter, Thomas
    Zeitz, Jonas
    Misselwitz, Benjamin
    Schoepfer, Alain
    Barry, Mamadou Pathe
    Rogler, Gerhard
    Biedermann, Luc
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2021, 9 (07) : 773 - 780
  • [28] Familial aggregation of inflammatory bowel disease on the Faroe Islands: a Faroese inflammatory bowel disease cohort study
    Nielsen, K. R.
    Olsen, J.
    Andorsdttir, G.
    Gislason, E.
    Burisch, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S440 - S441
  • [29] Impact of Inflammatory Bowel Disease on Disability
    Büsch K.
    Sonnenberg A.
    Bansback N.
    Current Gastroenterology Reports, 2014, 16 (10)
  • [30] Preventing disability in inflammatory bowel disease
    Allen, Patrick B.
    Gower-Rousseau, Corinne
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (11): : 865 - 876